THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN ™ MAY/JUNE 2012
VOLUME 5, NUMBER 3
FOR PAYERS, PURCHASERS, POLICYMAKERS, AND OTHER HEALTHCARE STAKEHOLDERS
EDITORIAL
“SCOTUS”: Will They or Won’t They? David B. Nash, MD, MBA CLINICAL
Managing Hypertension in the Elderly: A Common Chronic Disease with Increasing Age ™
Quang T. Nguyen, DO, FACE; Scott R. Anderson, MS IV; Lindsay Sanders, DO, MPH; Loida D. Nguyen, PharmD, BCPS Stakeholder Perspective by Katrina Moore, PharmD BUSINESS
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation Kate Fitch, RN, MEd; Jonah Broulette; Bruce Pyenson, FSA, MAAA; Kosuke Iwasaki, FIAJ, MAAA; Winghan Jacqueline Kwong, PharmD, PhD Stakeholder Perspective by Michael F. Murphy, MD, PhD
Recent Developments, Utilization, and Spending Trends for Pompe Disease Therapies Jing Guo, BPharm; Christina M.L. Kelton, PhD; Jeff J. Guo, PhD Stakeholder Perspective by Albert Tzeel, MD, MHSA, FACPE
AMCP 2012 HIGHLIGHTS
©2012 Engage Healthcare Communications, LLC www.AHDBonline.com